Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. (AMRX) Stock Overview
Explore Amneal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.8B
P/E Ratio
32.25
EPS (TTM)
$0.37
ROE
-1.45%
AMRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Amneal Pharmaceuticals, Inc. (AMRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 35.17, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $15.24.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.25 and a market capitalization of 3.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.